Jain Global »

Enanta Pharmaceuticals shares owned by Jain Global

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Jain Global from 13F filings

Historical chart of Jain Global investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Jain Global consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Jain Global

Quarter filed Position value Share count Share price at filing
2025-12-31 $198k 13k 15.77

More positions owned by Jain Global

Spdr Gold Tr Gold Shs (GLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Vaneck Etf Trust Gold Miners Etf (GDX)
Tesla Motors (TSLA)
Boeing Company (BA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation (NVDA)
Vaneck Etf Trust Junior Gold Mine (GDXJ)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr State Street Fin Call Option (XLF)
Spdr Series Trust State Street Spd Call Option (KRE)

View all positions for Jain Global

Top funds holding Enanta Pharmaceuticals

BlackRock
Farallon Capital Management
Krensavage Asset Management
Vanguard Group
Deep Track Capital
Henderson Group
Millennium Management
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Point72 Asset Management
Hillsdale Investment Management
Marshall Wace
Invesco

View all funds holding Enanta Pharmaceuticals